Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | NASDAQ | Biotechnology | $40.31B | $363.92 | -3.37% | $318.03M | 7,278.40x | 0.85 | Cayman Islands | ||
| CORT | CORCEPT THERAPEUTICS INC | NASDAQ | Biotechnology | $7.90B | $75.11 | -0.01% | $65.98M | 75.11x | 0.30 | United States | ||
| NVO | NOVO NORDISK A S | NYSE | Biotechnology | $211.29B | $47.55 | -1.88% | $24.81B | 13.22x | 2.02 | Denmark | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | NASDAQ | Biotechnology | $61.08B | $462.30 | 0.38% | $151.92M | 1,491.29x | 19.74 | United States | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | NYSEMKT | Biotechnology | $151.19M | $1.88 | -0.53% | $8.87M | 26.86x | 0.56 | Israel | ||
| ZVRA | ZEVRA THERAPEUTICS INC | NASDAQ | Biotechnology | $546.09M | $9.70 | 5.66% | $67.21M | 20.21x | 1.03 | United States | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | NASDAQ | Biotechnology | $3.13B | $41.28 | -0.29% | $53.58M | 84.24x | 0.33 | Bermuda | ||
| LGND | LIGAND PHARMACEUTICALS INC | NASDAQ | Biotechnology | $4.08B | $207.05 | 2.83% | $103.01M | 89.63x | 0.55 | United States | ||
| GMAB | GENMAB A | NASDAQ | Biotechnology | $19.47B | $30.32 | -0.33% | $2.00B | 12.94x | 0.22 | Denmark | ||
| ARGX | ARGENX SE | NASDAQ | Biotechnology | $56.06B | $918.53 | -1.19% | $811.30M | 36.71x | 0.18 | Belgium | ||
| VCEL | VERICEL CORP | NASDAQ | Biotechnology | $1.97B | $39.03 | -1.01% | $29.31M | 150.12x | 0.41 | United States | ||
| RPRX | ROYALTY PHARMA PLC | NASDAQ | Biotechnology | $22.78B | $39.46 | 0.77% | $1.04B | 22.42x | 1.01 | United States | ||
| KRYS | KRYSTAL BIOTECH INC | NASDAQ | Biotechnology | $5.94B | $204.74 | -1.69% | $193.29M | 29.67x | 0.09 | United States | ||
| TECH | BIO-TECHNE CORP | NASDAQ | Biotechnology | $9.06B | $58.15 | -0.78% | $220.90M | 116.30x | 0.29 | United States | ||
| CRMD | CORMEDIX INC | NASDAQ | Biotechnology | $793.80M | $10.08 | 0.95% | $112.26M | 4.44x | 1.01 | United States | ||
| HALO | HALOZYME THERAPEUTICS INC | NASDAQ | Biotechnology | $8.24B | $70.10 | -0.65% | $845.48M | 14.34x | 3.41 | United States | ||
| MDXG | MIMEDX GROUP INC | NASDAQ | Biotechnology | $995.25M | $6.72 | -5.35% | $69.21M | 24.00x | 0.34 | United States | ||
| GYRE | GYRE THERAPEUTICS INC | NASDAQ | Biotechnology | $738.88M | $7.67 | -4.36% | $13.23M | 109.57x | 0.22 | United States | ||
| VCYT | VERACYTE INC | NASDAQ | Biotechnology | $3.06B | $38.76 | -1.32% | $57.00M | 99.38x | 0.09 | United States | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | NASDAQ | Biotechnology | $10.40B | $54.16 | -0.55% | $772.70M | 19.91x | 0.26 | United States | ||
| VRTX | VERTEX PHARMACEUTICALS INC | NASDAQ | Biotechnology | $110.50B | $435.52 | 0.35% | $4.66B | 30.43x | 0.44 | United States | ||
| INCY | INCYTE CORP | NASDAQ | Biotechnology | $20.40B | $103.89 | -0.27% | $1.68B | 17.20x | 0.36 | United States | ||
| ADMA | ADMA BIOLOGICS INC | NASDAQ | Biotechnology | $3.73B | $15.69 | 1.75% | $172.13M | 17.83x | 0.32 | United States | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | NASDAQ | Biotechnology | $1.96B | $33.99 | 0.00% | $269.64M | 10.52x | 0.45 | United States | ||
| INVA | INNOVIVA INC | NASDAQ | Biotechnology | $1.64B | $21.87 | -0.46% | $214.76M | 11.57x | 0.42 | United States | ||
| AUPH | AURINIA PHARMACEUTICALS INC | NASDAQ | Biotechnology | $2.04B | $15.50 | 0.06% | $103.52M | 26.72x | 0.44 | Canada | ||
| EXEL | EXELIXIS INC | NASDAQ | Biotechnology | $11.43B | $42.65 | 0.54% | $927.60M | 17.34x | 0.31 | United States | ||
| MNKD | MANNKIND CORP | NASDAQ | Biotechnology | $1.55B | $5.06 | 1.61% | $73.18M | 50.60x | -12.10 | United States | ||
| REGN | REGENERON PHARMACEUTICALS INC | NASDAQ | Biotechnology | $76.23B | $725.34 | 2.99% | $5.71B | 16.69x | 0.30 | United States | ||
| UTHR | UNITED THERAPEUTICS CORP | NASDAQ | Biotechnology | $20.52B | $476.59 | 0.99% | $1.77B | 16.73x | 0.12 | United States | ||
| CPRX | CATALYST PHARMACEUTICALS INC | NASDAQ | Biotechnology | $2.79B | $22.66 | 0.44% | $323.88M | 12.66x | 0.14 | United States |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.